-+ 0.00%
-+ 0.00%
-+ 0.00%
Oruka Therapeutics Director Kristine M. Ball Sells Common Shares Worth $1.89 Million
Share
Listen to the news
Oruka Therapeutics Director Kristine M. Ball Sells Common Shares Worth $1.89 Million
  • Oruka Therapeutics director Kristine M. Ball sold 18,000 common shares on Nov. 12, 2026, leaving no directly held common stock.
  • She exercised 18,000 stock options at $6.84 per share, retaining 53,426 directly held stock options.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oruka Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000907654-26-000115), on November 13, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending